相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B
Manon Fuchs et al.
BMC BIOTECHNOLOGY (2014)
Human- like antibodies neutralizing Western equine encephalitis virus
Birgit Huelseweh et al.
MABS (2014)
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library
Sebastian Miethe et al.
MABS (2014)
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
Volker Jaeger et al.
BMC BIOTECHNOLOGY (2013)
Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Ab: A Biotechnical Tool for Studies on Alzheimer's Disease?
Silke Dornieden et al.
PLOS ONE (2013)
Human LilrB2 Is a β-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
Taeho Kim et al.
SCIENCE (2013)
Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future
Niels D. Prins et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Jens Moreth et al.
IMMUNITY & AGEING (2013)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
Torsten Ruelker et al.
PLOS ONE (2012)
Brain Imaging in Alzheimer Disease
Keith A. Johnson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species
Asad Jan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A human scFv antibody generation pipeline for proteome research
Michael Hust et al.
JOURNAL OF BIOTECHNOLOGY (2011)
PERSPECTIVE In search of biomarkers
Neil S. Buckholtz
NATURE (2011)
Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils
Mahiuddin Ahmed et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta
Vitaly Vasilevko et al.
NEUROBIOLOGY OF DISEASE (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
Thibaut Pelat et al.
BMC BIOTECHNOLOGY (2009)
Aβ(1-40) Fibril Polymorphism Implies Diverse Interaction Patterns in Amyloid Fibrils
Jessica Meinhardt et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics
Thibaut Pelat et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus
Mark Schuette et al.
PLOS ONE (2009)
Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers
Remy Robert et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity
Asad Jan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils
Gernot Habicht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation
Thibaut Pelat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Positron emission tomography metabolic correlates of apathy in Alzheimer disease
Gad A. Marshall et al.
ARCHIVES OF NEUROLOGY (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Inhibitors of amyloid toxicity based on β-sheet packing of Aβ40 and Aβ42
T Sato et al.
BIOCHEMISTRY (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
The α-to-β conformational transition of Alzheimer's Aβ-(1-42) peptide in aqueous media is reversible:: A step by step conformational analysis suggests the location of β conformation seeding
S Tomaselli et al.
CHEMBIOCHEM (2006)
Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694
E Laffly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Neurotoxic protein oligomers - what you see is not always what you get
G Bitan et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2005)
Survival following dementia onset: Alzheimer's disease and vascular dementia
AL Fitzpatrick et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
A beta 42 immunization in Alzheimer's disease generates A beta N-terminal antibodies
M Lee et al.
ANNALS OF NEUROLOGY (2005)
Effect of different anti-Aβ antibodies on Aβ fibrillogenesis as assessed by atomic force microscopy
J Legleiter et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Alzheimer's disease Aβ vaccine reduces central nervous system Aβ levels in a non-human primate, the Caribbean Vervet
CA Lemere et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Humoral immune response to fibrillar β-amyloid peptide
DL Miller et al.
BIOCHEMISTRY (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
F Bard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4-10 and inhibit cytotoxicity and fibrillogenesis
J McLaurin et al.
NATURE MEDICINE (2002)
The SPOT synthesis technique - Synthetic peptide arrays on membrane supports - principles and applications
R Frank
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
KN Dahlgren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Amyloid-β oligomers:: their production, toxicity and therapeutic inhibition
DM Walsh et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Conformational Abs recognizing a generic amyloid fibril epitope
B O'Nuallain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells
Y Durocher et al.
NUCLEIC ACIDS RESEARCH (2002)
Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration
D Frenkel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
